Back to results
CompletedPhase 1Phase 2

Activity of AVE1625 in Mild to Moderate Alzheimer's Patients.

NCT00380302

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Sanofi-Aventis Administrative Office

Bridgewater, New Jersey, United States

+4 additional locations

View on ClinicalTrials.gov
Activity of AVE1625 in Mild to Moderate Alzheimer's Patients. — TrialFind